A

Absentia Labs

AI-driven whole-organism modeling for drug safety

AI Research Scientist

AI ResearchConfirmed live in the last 24 hours
ContractBoston, MA, USAHybrid

About the Job

Requirements

  • A strong research track record demonstrated through publications, novel methods, significant open-source research, or technically substantial research projects.
  • Deep understanding of modern machine learning and deep learning.
  • Hands-on experience developing and evaluating models in PyTorch, JAX, or equivalent frameworks.
  • Experience with one or more of graph neural networks, transformers, representation learning, multimodal learning, generative modeling, self-supervised learning, probabilistic modeling, or foundation models.
  • Experience designing controlled evaluations, ablations, and reproducible research.
  • Ability to reason carefully about dataset construction, leakage, confounding, generalization, and evaluation methodology.
  • Ability to independently identify important research questions and carry projects from initial hypothesis through rigorous experimental results.
  • Strong written and verbal communication skills.

Responsibilities

  • Own ambitious research problems in predictive toxicology, drug safety, and computational biology from hypothesis through experimental validation.
  • Develop and evaluate novel deep learning architectures and training methods, including graph neural networks, transformers, multimodal models, generative approaches, and other emerging architectures where scientifically appropriate.
  • Investigate representations connecting molecular structure, biological targets, pathways, dose and exposure, pharmacology, toxicology, and clinical outcomes.
  • Develop approaches for learning from heterogeneous, sparse, noisy, and partially observed scientific datasets.
  • Explore methods for cross-domain and out-of-distribution generalization, including prediction on novel compounds, chemical spaces, biological contexts, and endpoints.
  • Design rigorous experiments, benchmarks, ablations, and evaluation frameworks to distinguish genuine biological generalization from memorization or dataset artifacts.
  • Develop methods for uncertainty estimation, calibration, applicability-domain assessment, and confidence-aware prediction.
  • Investigate approaches to make model predictions more mechanistically interpretable, including identifying biological pathways, targets, systems, and evidence contributing to predicted outcomes.
  • Explore multimodal and foundation-model approaches that combine chemical, biological, experimental, literature-derived, and clinical evidence.
  • Identify limitations and failure modes in existing models and turn those observations into new research directions.
  • Work with AI/ML and data engineers to translate successful research into reproducible, scalable modeling systems.
  • Contribute to scientific strategy, including validation studies, external scientific collaborations, publications, and research supporting regulatory evaluation of the models.

Desired Qualifications

  • Computational biology, computational chemistry, cheminformatics, or drug discovery.
  • Molecular machine learning or geometric deep learning.
  • Biological foundation models.
  • Multimodal scientific machine learning.
  • Causal inference or mechanistic modeling.
  • Uncertainty quantification and model calibration.
  • Out-of-distribution/generalization research.
  • Active learning or experimental design.
  • Pharmacology, toxicology, PK/PD, or translational science.
  • Experience working with large scientific or biomedical datasets.
  • Research spanning machine learning and the natural sciences.

About the Company

Absentia Labs

AI-driven whole-organism modeling for drug safety

Absentia Labs builds an AI-driven, organism-wide modeling platform that helps biotech and pharmaceutical teams assess drug safety and translational risk early in development. Its core AI-native engine combines biological, chemical, and assay data to simulate how a drug behaves in the body across whole organs, predicting efficacy and safety issues before preclinical tests. By focusing on organ-specific risks like liver, heart, and kidney liabilities, the platform aims to identify problem candidates early and guide which drugs to advance. This approach is designed to reduce late-stage failures and speed up the process of bringing medicines to the clinic, offering a more ethical and cost-effective alternative to traditional animal testing. Absentia Labs positions itself as the intelligence layer for molecular medicine, working with universities and biopharma partners to standardize and accelerate drug discovery and development.

Company size
Not listed
Company stage
Not listed
Total funding
Not listed
Headquarters
Somerville, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Absentia Labs

See more jobs